Company intelligence / Profile preview
Jubilant DraxImage
Kirkland, Montreal, Quebec, Canadadraximage.com ↗
- Ownership
- Private
- Employees
- ~170
- Development stage
- Commercial
01
Overview
Jubilant DraxImage develops, manufactures, and commercializes radiopharmaceuticals used in the detection and treatment of various diseases including thyroid cancer. Key products include I-131 Therapeutic & Diagnostic capsules (thyroid), Methylene-Diphosphonate (bone), and MacroAggregated Albumin (lung)[3].
- Therapeutic areas
- OncologyPulmonologyCardiovascularEndocrinology
- Modalities
- Radiopharmaceuticals
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Cyclopharm Ltd (for Technegas)
Beyond the preview
Go deeper on Jubilant DraxImage.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jubilant DraxImage.